Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter
Deanna J. Buehrle, Brooke K. Decker, Marilyn M. Wagener, Amesh A. Adalja, Nina Singh, M. Catherine McEllistrem, M. Hong Nguyen, Cornelius J. Clancy
Abstract
There are scant data on the impact of coronavirus disease 2019 (COVID-19) on hospital antibiotic consumption, and no data from outside epicenters. At our nonepicenter hospital, antibiotic days of therapy (DOT) and bed days of care (BDOC) were reduced by 151.5/month and 285/month, respectively, for March to June 2020 compared to 2018–2019 ( P = 0.001 and P < 0.001). DOT per 1,000 BDOC was increased (8.1/month; P = 0.
Topics & Concepts
Antibiotic StewardshipAntibioticsCoronavirus disease 2019 (COVID-19)PandemicMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antimicrobial stewardshipStewardship (theology)Consumption (sociology)Antibiotic resistanceDiseaseIntensive care medicineInternal medicineMicrobiologyInfectious disease (medical specialty)BiologySocial scienceLawPoliticsPolitical scienceSociologyAntibiotic Use and ResistancePatient Satisfaction in HealthcareEmergency and Acute Care Studies